Bone Biologics Corporation (BBLG)Healthcare | Biotechnology | Burlington, United States | NasdaqCM
1.40 USD
+0.01
(1.087%)
⇧
(April 21, 2026, 3:27 p.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ★★★☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 18, 2026, 10:26 p.m. EDT
BBLG presents as a speculative biotech turnaround candidate with strong technical trend reversal and deep value metrics, but trading on heavy bearish momentum from the model and lacking any dividend yield or earnings stability. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.273142 |
| AutoETS | 0.283801 |
| MSTL | 0.289680 |
| AutoARIMA | 0.309732 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 1.68 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 1.21 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 2,504,387 |
| Forward P/E | -0.86 |
| Beta | 0.37 |
| Website | https://www.bonebiologics.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.67375886 |
| Address1 | 2 Burlington Woods Drive |
| Address2 | Suite 100 |
| All Time High | 10,255.68 |
| All Time Low | 1.05 |
| Ask | 1.77 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 11,360 |
| Average Daily Volume3 Month | 18,377 |
| Average Volume | 18,377 |
| Average Volume10Days | 11,360 |
| Beta | 0.367 |
| Bid | 0.9936 |
| Bid Size | 2 |
| Book Value | 2.995 |
| City | Burlington |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.395 |
| Current Ratio | 13.847 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.395 |
| Day Low | 1.38 |
| Display Name | Bone Biologics |
| Dividend Date | 1,532,390,400 |
| Earnings Timestamp End | 1,754,942,400 |
| Earnings Timestamp Start | 1,754,596,800 |
| Ebitda Margins | 0.0 |
| Enterprise Value | -2,856,863 |
| Eps Current Year | -1.93 |
| Eps Forward | -1.62 |
| Eps Trailing Twelve Months | -2.65 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.22456 |
| Fifty Day Average Change | 0.17043996 |
| Fifty Day Average Change Percent | 0.13918465 |
| Fifty Two Week Change Percent | -67.375885 |
| Fifty Two Week High | 6.75 |
| Fifty Two Week High Change | -5.355 |
| Fifty Two Week High Change Percent | -0.79333335 |
| Fifty Two Week Low | 1.05 |
| Fifty Two Week Low Change | 0.34500003 |
| Fifty Two Week Low Change Percent | 0.32857147 |
| Fifty Two Week Range | 1.05 - 6.75 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,634,131,800,000 |
| Float Shares | 1,794,578 |
| Forward Eps | -1.62 |
| Forward P E | -0.8611111 |
| Free Cashflow | -1,650,181 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 2 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00037999998 |
| Held Percent Institutions | 0.02853 |
| Implied Shares Outstanding | 1,795,260 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-10-13 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,749,513,600 |
| Last Split Factor | 1:6 |
| Long Business Summary | Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts. |
| Long Name | Bone Biologics Corporation |
| Market | us_market |
| Market Cap | 2,504,387 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_99330767 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -3,108,991 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 2,477,458 |
| Number Of Analyst Opinions | 1 |
| Open | 1.39 |
| Operating Cashflow | -2,691,150 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 781 552 4452 |
| Previous Close | 1.38 |
| Price Eps Current Year | -0.72279793 |
| Price Hint | 4 |
| Price To Book | 0.4657763 |
| Profit Margins | 0.0 |
| Quick Ratio | 12.767 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.014999986 |
| Regular Market Change Percent | 1.0869555 |
| Regular Market Day High | 1.395 |
| Regular Market Day Low | 1.38 |
| Regular Market Day Range | 1.38 - 1.395 |
| Regular Market Open | 1.39 |
| Regular Market Previous Close | 1.38 |
| Regular Market Price | 1.395 |
| Regular Market Time | 1,776,799,624 |
| Regular Market Volume | 4,251 |
| Return On Assets | -0.41871 |
| Return On Equity | -0.70171 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 1,795,260 |
| Shares Percent Shares Out | 0.008 |
| Shares Short | 14,344 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 30,363 |
| Short Name | Bone Biologics Corp |
| Short Percent Of Float | 0.008 |
| Short Ratio | 0.72 |
| Source Interval | 15 |
| State | MA |
| Symbol | BBLG |
| Target High Price | 22.2 |
| Target Low Price | 22.2 |
| Target Mean Price | 22.2 |
| Target Median Price | 22.2 |
| Total Cash | 5,334,322 |
| Total Cash Per Share | 2.971 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.65 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.91476 |
| Two Hundred Day Average Change | -0.51976 |
| Two Hundred Day Average Change Percent | -0.27144918 |
| Type Disp | Equity |
| Volume | 4,251 |
| Website | https://www.bonebiologics.com |
| Zip | 1,803 |